Literature DB >> 16463141

State-dependent block of human cardiac hNav1.5 sodium channels by propafenone.

T Edrich1, S-Y Wang, G K Wang.   

Abstract

State-dependent blockade of human cardiac hNav1.5 sodium channels by propafenone was studied using whole-cell patch clamp techniques. Both a direct investigation using cells with inactivation-deficient sodium channels and an algorithmic approach used on cells with wild-type channels revealed a rapid binding of propafenone to the open state. This occurs approximately 4000 and 700 times faster than the binding to the resting and inactivated state, respectively. An established mathematical "gating" model was modified to represent the experimental data.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16463141     DOI: 10.1007/s00232-005-0801-4

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  15 in total

1.  Quantitative modelling of interaction of propafenone with sodium channels in cardiac cells.

Authors:  M Pásek; J Simurda
Journal:  Med Biol Eng Comput       Date:  2004-03       Impact factor: 2.602

2.  Kinetic analysis of phasic inhibition of neuronal sodium currents by lidocaine and bupivacaine.

Authors:  D M Chernoff
Journal:  Biophys J       Date:  1990-07       Impact factor: 4.033

3.  Block of single cardiac Na+ channels by antiarrhythmic drugs: the effect of amiodarone, propafenone and diprafenone.

Authors:  M Kohlhardt; H Fichtner
Journal:  J Membr Biol       Date:  1988-05       Impact factor: 1.843

4.  Gating of the squid sodium channel at positive potentials: II. Single channels reveal two open states.

Authors:  A M Correa; F Bezanilla
Journal:  Biophys J       Date:  1994-06       Impact factor: 4.033

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

6.  A reinterpretation of mammalian sodium channel gating based on single channel recording.

Authors:  R W Aldrich; D P Corey; C F Stevens
Journal:  Nature       Date:  1983 Dec 1-7       Impact factor: 49.962

7.  Clinical pharmacology of propafenone.

Authors:  S J Connolly; R E Kates; C S Lebsack; D C Harrison; R A Winkle
Journal:  Circulation       Date:  1983-09       Impact factor: 29.690

8.  Stereoselective interactions of (R)- and (S)-propafenone with the cardiac sodium channel.

Authors:  W Schreibmayer; W Lindner
Journal:  J Cardiovasc Pharmacol       Date:  1992-08       Impact factor: 3.105

9.  Tryptophan scanning of D1S6 and D4S6 C-termini in voltage-gated sodium channels.

Authors:  Sho-Ya Wang; Kaitlin Bonner; Corinna Russell; Ging Kuo Wang
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

10.  Molecular mechanism for an inherited cardiac arrhythmia.

Authors:  P B Bennett; K Yazawa; N Makita; A L George
Journal:  Nature       Date:  1995-08-24       Impact factor: 49.962

View more
  9 in total

1.  Mechanisms of atrial-selective block of Na⁺ channels by ranolazine: II. Insights from a mathematical model.

Authors:  Vladislav V Nesterenko; Andrew C Zygmunt; Sridharan Rajamani; Luiz Belardinelli; Charles Antzelevitch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-05       Impact factor: 4.733

2.  Reporting sodium channel activity using calcium flux: pharmacological promiscuity of cardiac Nav1.5.

Authors:  Hongkang Zhang; Beiyan Zou; Fang Du; Kaiping Xu; Min Li
Journal:  Mol Pharmacol       Date:  2014-11-24       Impact factor: 4.436

3.  Pharmacology of the Nav1.1 domain IV voltage sensor reveals coupling between inactivation gating processes.

Authors:  Jeremiah D Osteen; Kevin Sampson; Vivek Iyer; David Julius; Frank Bosmans
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-12       Impact factor: 11.205

4.  State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine.

Authors:  Ging Kuo Wang; Joanna Calderon; Sho-Ya Wang
Journal:  Mol Pharmacol       Date:  2007-12-13       Impact factor: 4.436

5.  Persistent human cardiac Na+ currents in stably transfected mammalian cells: Robust expression and distinct open-channel selectivity among Class 1 antiarrhythmics.

Authors:  Ging Kuo Wang; Gabriella Russell; Sho-Ya Wang
Journal:  Channels (Austin)       Date:  2013 Jul-Aug       Impact factor: 2.581

Review 6.  The role of late I Na in development of cardiac arrhythmias.

Authors:  Charles Antzelevitch; Vladislav Nesterenko; John C Shryock; Sridharan Rajamani; Yejia Song; Luiz Belardinelli
Journal:  Handb Exp Pharmacol       Date:  2014

7.  Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype.

Authors:  Inseok Hwang; Je-Wook Park; Oh-Seok Kwon; Byounghyun Lim; Myunghee Hong; Min Kim; Hee-Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Boyoung Joung; Moon-Hyoung Lee; Hui-Nam Pak
Journal:  Front Physiol       Date:  2021-05-13       Impact factor: 4.566

8.  In silico Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome.

Authors:  Dominic G Whittaker; Jules C Hancox; Henggui Zhang
Journal:  Front Physiol       Date:  2019-01-11       Impact factor: 4.566

9.  Tetrodotoxin-Sensitive Neuronal-Type Na+ Channels: A Novel and Druggable Target for Prevention of Atrial Fibrillation.

Authors:  Mark A Munger; Yusuf Olğar; Megan L Koleske; Heather L Struckman; Jessica Mandrioli; Qing Lou; Ingrid Bonila; Kibum Kim; Roberto Ramos Mondragon; Silvia G Priori; Pompeo Volpe; Héctor H Valdivia; Joseph Biskupiak; Cynthia A Carnes; Rengasayee Veeraraghavan; Sándor Györke; Przemysław B Radwański
Journal:  J Am Heart Assoc       Date:  2020-05-29       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.